1
项与 [131I] ICF01012 相关的临床试验Targeted Radionuclide Therapy for Metastatic Melanoma [131I] ICF01012: Phase I Study
This study is a phase I clinical trial aimed to determine the recommended dose of [131I]ICF01012 to administer for the treatment of patients with pigmented metastatic melanoma (binding [131I]ICF01012 ). The [131I]ICF01012 is a targeted radionuclide therapy with a high affinity for melanin.
100 项与 [131I] ICF01012 相关的临床结果
100 项与 [131I] ICF01012 相关的转化医学
100 项与 [131I] ICF01012 相关的专利(医药)
100 项与 [131I] ICF01012 相关的药物交易